Jump to Content Jump to Main Navigation

Zentiva/Alvogen CEE pharma merger case, Al Sirona (Luxembourg) Acquisition Sárl v Alvogen CEE Kft, Final NCA decision, Case No Vj-2/2020, OCL 292 (HU 2020), 26th March 2020, Hungary; Hungarian Competition Authority [GVH]

From: Oxford Competition Law (http://oxcat.ouplaw.com). (c) Oxford University Press, 2021. All Rights Reserved.date: 27 July 2021

Whether a merger in the pharmaceuticals industry would lead to a significant lessening of competition.

When a proposed commitment can be examined by a national competition authority.

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.